Literature DB >> 3658500

Respiratory syncytial virus infection and cardiopulmonary disease.

D A Laufer1, P J Edelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3658500     DOI: 10.3928/0090-4481-19870801-10

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


× No keyword cloud information.
  1 in total

Review 1.  Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.

Authors:  N J Snell
Journal:  Lung       Date:  1990       Impact factor: 2.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.